Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
N413682-1mg | 1mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $45.90 | |
N413682-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $129.90 | |
N413682-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $179.90 | |
N413682-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $344.90 | |
N413682-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $525.90 | |
N413682-100mg | 100mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $757.90 |
Synonyms | A924416 | Q27089277 | D87151 | EX-A1929 | CHEBI:166857 | HY-138941 | NASTORAZEPIDE [INN] | R-(-)-Z-360 Free acid | GTPL907 | (R)-(-)-3-[3-(1-tert-butylcarbonylmethyl-2-oxo-5-cyclohexyl-1,3,4,5-tetrahydro-2H-1,5-benzodiazepin-3-yl)ureido]benzoic acid | NCG |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Nastorazepide (Z-360) is a selective, orally available antagonist of 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST |
Mechanism of action | Antagonist of CCK 2 receptor |
Product Description | Information Nastorazepide (Z-360) is a selective, orally available antagonist of 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor with potential antineoplastic activity. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 3-[[(3R)-1-cyclohexyl-5-(3,3-dimethyl-2-oxobutyl)-4-oxo-2,3-dihydro-1,5-benzodiazepin-3-yl]carbamoylamino]benzoic acid |
---|---|
INCHI | InChI=1S/C29H36N4O5/c1-29(2,3)25(34)18-33-24-15-8-7-14-23(24)32(21-12-5-4-6-13-21)17-22(26(33)35)31-28(38)30-20-11-9-10-19(16-20)27(36)37/h7-11,14-16,21-22H,4-6,12-13,17-18H2,1-3H3,(H,36,37)(H2,30,31,38)/t22-/m1/s1 |
InChi Key | VIJCCFFEBCOOIE-JOCHJYFZSA-N |
Canonical SMILES | CC(C)(C)C(=O)CN1C2=CC=CC=C2N(CC(C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4 |
Isomeric SMILES | CC(C)(C)C(=O)CN1C2=CC=CC=C2N(C[C@H](C1=O)NC(=O)NC3=CC=CC(=C3)C(=O)O)C4CCCCC4 |
PubChem CID | 9872609 |
Molecular Weight | 520.6 |
PubChem CID | 9872609 |
---|---|
CAS Registry No. | 209219-38-5 |
GPCRdb Ligand | Z-360 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
G2416533 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416534 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416580 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416581 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416582 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416583 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416584 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416585 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416586 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416587 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416588 | Certificate of Analysis | Apr 01, 2024 | N413682 |
G2416589 | Certificate of Analysis | Apr 01, 2024 | N413682 |
Solubility | DMSO: 30 mg/mL (57.63 mM) |
---|